Quantessence Capital LLC Emergent Bio Solutions Inc. Transaction History
Quantessence Capital LLC
- $400 Billion
- Q1 2025
A detailed history of Quantessence Capital LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Quantessence Capital LLC holds 43,817 shares of EBS stock, worth $240,555. This represents 0.05% of its overall portfolio holdings.
Number of Shares
43,817Holding current value
$240,555% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding EBS
# of Institutions
178Shares Held
37.6MCall Options Held
94.1KPut Options Held
153K-
Black Rock Inc. New York, NY3.84MShares$21.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$17.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.5MShares$13.7 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO2.3MShares$12.6 Million0.01% of portfolio
-
State Street Corp Boston, MA1.71MShares$9.39 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $274M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...